Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessNET, the Company’s PACS product at the upcoming RSNA 2009 Annual Meeting held at...
Aspyra, Inc. (AMEX: APY) today announced that is has given notice to NYSE Amex (the “Exchange”) of its decision to voluntarily delist its common stock from the Exchange and...
Aspyra, Inc. (AMEX: APY) today announced the release of CyberLAB version 7.2.5, for general distribution to existing and new Laboratory Information System customers...
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at...
Aspyra, Inc. (AMEX: APY), a provider of clinical and diagnostic information systems for the healthcare industry, today reported it has received notice from NYSE Amex LLC (the...
Aspyra, Inc. (AMEX:APY) announced today that the Company has contracted with Renaissance Radiology Medical Group, Inc., a leading provider of outpatient diagnostic services...
Aspyra, Inc. (AMEX: APY), a provider of clinical and diagnostic information systems for the healthcare industry, today reported its results of operations for the second quarter...
Aspyra, Inc. (AMEX:APY) announced today that the Company has entered into an agreement with Valley View Regional Hospital (VVRH), a 142-licensed bed facility located in Ada...
Aspyra, Inc. (AMEX:APY), a provider of clinical and diagnostic information systems for the healthcare industry, today reported its results of operations for the first quarter...
Aspyra, Inc. (AMEX: APY) announced today that the Company has entered into an agreement with Springfield Clinic, LLP, one of the largest multi-specialty physicians groups in...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
